“The controversial coronavirus drug that a Hasidic doctor has been using to treat hundreds of people with moderate symptoms in upstate N.Y. is also being tried by doctors in at least three other states, and New York health officials have started using it to treat critically ill patients in hospitals.”
https://forward.com/news/national/442511/trump-coronavirus-fda/
May 4, 2021 This article is about the “8th Day Therapy” concept developed by Dr Shankara Chetty from South Africa, who has treated… (146)
August 15, 2020 Australian radio host Luke Bona interviewed this August 12 Professor Thomas Borody, from the Centre for Digestive Diseases in Sydney,… (131)
September 18, 2021 This interview with Jessica Rose, PhD, covers the question of vaccine safety, as it can be evaluated from actual real… (89)
August 15, 2023 The event was organized at the Brussels facilities of the European Parliament. This was made possible by a handful of… (72)
December 21, 2021 In this interview with internationally renowned Dr. Shankara Chetty from South Africa, we discuss the Omicron variant, which is taking… (71)
August 19, 2020 The Centre for Digestive Diseases issued today a press release titled “Ivermectin Triple Therapy Protocol for COVID-19 Released to Australian… (71)
April 18, 2021 This is an audio presentation by Dr Henry Early about Vitamin D in relation to COVID-19. Dr Henry Ealy is… (65)
April 9, 2020 The new study, of which the abstract was released today, was performed at IHU Méditerranée Infection, Marseille, France. A cohort… (59)
March 24, 2021 One of the most active analysts during this pandemic regarding the treatment of COVID-19 has been independent researcher Adam Gaertner.… (48)
August 30, 2023 Let’s summarize here the key points of our analysis, which shows that there is little rationale for any massive &… (48)
Greetings and welcome. COVEXIT.com offers you independent global news and policy analysis regarding COVID-19, with emphasis on early treatments.
We are on Spotify and Apple Podcasts! Check our page listing all our podcasts.
We are on Twitter and also on GAB and Mewe.
Bonjour. Nous aurons prochainement du contenu nouveau via Substack. Vous êtes invité à vous y abonner!
